Nephrology Doctors in Portsmouth, NH Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Dr. Sucharit Suresh Joshi, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, #c-10, Portsmouth, NH 03801 Phone: 603-436-3433    Fax: 603-427-5115

Dr. Michael Casimir Danielski, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, #c-10, Portsmouth, NH 03801 Phone: 603-436-3433    Fax: 603-427-5115

Dr. Shiv Kumar, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, Building C-unit 10, Portsmouth, NH 03801 Phone: 603-422-6719    Fax: 603-373-6833

Dr. Kulli M Barrett, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 330 Borthwick Ave, Suite 100, Portsmouth, NH 03801 Phone: 603-436-3433    Fax: 603-427-5115

Dr. Naresh Matta, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, #c-10, Portsmouth, NH 03801 Phone: 603-436-3433    Fax: 603-427-5115

News Archive

The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells

Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia.

GeoVax Labs Labs announces 1-for-50 reverse stock split

GeoVax Labs, Inc., a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, today announced it will implement a 1-for-50 reverse stock split effective following the close of business on April 27, 2010. After the reverse stock split, the Company will be authorized to issue up to 40 million shares of stock, of which approximately 15.7 million shares will be outstanding.

Association for Gerontology in Higher Education to hold 37th Annual Conference, March 17-20 in Cincinnati

The Association for Gerontology in Higher Education (AGHE) - the educational branch of The Gerontological Society of America - will hold its 37th Annual Meeting and Educational Leadership Conference from March 17 to 20 at the Hilton Cincinnati Netherland Plaza in Cincinnati, OH.

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.

Read more Medical News

› Verified 9 days ago